Sex differences in risk for coronary heart disease mortality associated with diabetes and established coronary heart disease

Archives of Internal Medicine

Volumn 163, Issue 14, 2003, Pages 1735-1740

  Natarajan, Sundar ^a,b,c,e   Liao, Youlian ^b   Cao, Guichan ^b   Lipsitz, Stuart R ^b   McGee, Daniel L ^d  

^a RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d FLORIDA STATE UNIVERSITY   (United States)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL;

ADULT; AGE; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING;

ADULT; AGE FACTORS; AGED; BODY MASS INDEX; CHOLESTEROL, LDL; CORONARY DISEASE; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTORS; SEX FACTORS; SMOKING; STATISTICS;

EID: 0042308631     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.163.14.1735     Document Type: Article

References (38)

1. Labarthe DR. Epidemiology and Prevention of Cardiovascular Diseases: A Global Challenge. Gaithersburg, Md: Aspen Publishers; 1998.
2. Chambless L, Keil U, Dobson A, et al. Population versus clinical view of case fatality from acute coronary heart disease: results from the WHO MONICA Project 1985-1990: Multinational Monitoring of Trends and Determinants in Cardiovascular Disease. Circulatton. 1997;96:3849-3859.
3. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339:229-234.
4. Mosca L, Grundy SM, Judelson D, et al. Guide to Preventive Cardiology for Women: AHA/ACC Scientific Statement Consensus panel statement. Circulatton. 1999; 99:2480-2484.
5. Gu K, Cowie CC, Harris MI. Diabetes and decline in heart disease mortality in US adults. JAMA. 1999;281:1291-1297.
6. American Diabetes Association: clinical practice recommendations 2001. Diabetes Care. 2001;24(suppl 1):S1-121.
7. Barrett-Connor EL, Cohn BA, Wingard DL, Edelstein SL. Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? the Rancho Bernardo Study. JAMA. 1991;265:627-631.
8. Dawber TR, Meadors GF, Moore FE. Epidemiologic approaches to heart disease: the Framingham Study. Am J Public Health. 1951;41:279-286.
9. Kannel WB, Feinleib M, McNamara PM, Garrison RJ, Castelli WP. An investigation of coronary heart disease in families: the Framingham Offspring Study. Am J Epidemiol. 1979;110:281-290.
10. Shurtleff D. Some characteristics related to the incidence of cardiovascular disease and death: Framingham Heart Study 18-year follow-up. In: Kannel WB GT, ed. The Framingham Study: An Epidemiological Investigation of Cardiovascular Disease. Section 30. Washington, DC: US Government Printing Office; 1974:17-25.
11. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1997;157:2413-2446.
12. Efron B. An Introduction to the Bootstrap. New York, NY: Chapman & Hall; 1993.
13. SAS/STAT User's Guide. Cary, NC: SAS Institute Inc; 1999.
14. Manson JE, Colditz GA, Stampfer MJ, et al. A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med. 1991;151:1141-1147.
15. Walden CE, Knopp RH, Wahl PW, Beach KW, Strandness E Jr. Sex differences in the effect of diabetes mellitus on lipoprotein triglyceride and cholesterol concentrations. N Engl J Med. 1984;311:953-959.
16. Howard BV, Cowan LD, Go O, Welty TK, Robbins DC, Lee ET. Adverse effects of diabetes on multiple cardiovascular disease risk factors in women: the Strong Heart Study. Diabetes Care. 1998;21:1258-1265.
17. Evans RW, Orchard TJ. Oxidized lipids in insulin-dependent diabetes mellitus: a sex-diabetes interaction? Metabolism. 1994;43:1196-1200.
18. Sowers JR. Insulin and insulin-like growth factor in normal and pathological cardiovascular physiology. Hypertension. 1997;29:691-9.
19. Steinberg HO, Paradisi G, Cronin J, et al. Type II diabetes abrogates sex differences in endothelial function in premenopausal women. Circulation. 2000;101: 2040-2046.
20. Chaitman BR, Bourassa MG, Davis K, et al. Angiographic prevalence of high-risk coronary artery disease in patient subsets (CASS). Circulation. 1981;64: 360-367.
21. Rentrop KP, Thornton JC, Feit F, Van Buskirk M. Determinants and protective potential of coronary arterial collaterals as assessed by an angioplasty model. Am J Cardiol. 1988;61:677-684.
22. Williams DO, Amsterdam EA, Miller RR, Mason DT. Functional significance of coronary collateral vessels in patients with acute myocardial infarction: relation to pump performance, cardiogenic shock and survival. Am J CardioL 1976;37: 345-351.
23. Kannel WB, Abbott RD. Incidence and prognosis of myocardial infarction in women: the Framingham Study. In: Eaker ED, Wenger NK, Clarkson TB, Tyroler HA, eds. Coronary Heart Disease in Women. Bethesda, Md: National Heart, Lung, and Blood Institute, National Institutes of Health; 1987.
24. Committee on Understanding the Biology of Sex and Gender Differences, Institute of Medicine. Sex affects health. In: Wizemann TM, Pardue M, eds. Exploring the Biological Contributions to Human Health: Does Sex Matter? Washington, DC: National Academy Press; 2001:93-136.
25. Gu K, Cowie CC, Harris MI. Mortality in adults with and without diabetes in a national cohort of the US population, 1971-1993. Diabetes Care. 1998;21:1138-1145.
26. Abbott RD, Donahue RP, Kannel WB, Wilson PW. The impact of diabetes on survival following myocardial infarction in men vs women: the Framingham Study. JAMA. 1988;260:3456-3460.
27. Hu FB, Stampfer MJ, Solomon CG, et al. The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up. Arch Intern Med. 2001;161:1717-1723.
28. Colditz GA, Martin P, Stampfer MJ, et al. Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol. 1986;123:894-900.
29. Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in US adults: the Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care. 1998;21:518-24.
30. Lotufo PA, Gaziano JM, Chae CU, et al. Diabetes and all-cause and coronary heart disease mortality among US male physicians. Arch Intern Med. 2001;161:242-247.
31. Malmberg K, Yusuf S, Gerstein HC, et al. Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry. Circulation. 2000;102:1014-1019.
32. Miettinen H, Lehto S, Salomaa V, et al. Impact of diabetes on mortality after the first myocardial infarction: the FINMONICA Myocardial Infarction Register Study Group. Diabetes Care. 1998;21:69-75.
33. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33): UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998; 352:837-53.
34. Staessen JA, Thijs L, Gasowski J, Cells H, Fagard RH. Treatment of isolated systolic hypertension in the elderly: further evidence from the Systolic Hypertension in Europe (Syst-Eur) trial. Am J Cardiol. 1998;82:20R-22R.
35. Haffner SM, Alexander CM, Cock TJ, et al. Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the Scandinavian Simvastatin Survival Study. Arch Intern Med. 1999;159:2661-2667.
36. Colwell JA. Aspirin therapy in diabetes. Diabetes Care. 1997;20:1767-1771.
37. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21:1414-1431.
38. Grover SA, Coupal L, Zowall H, Alexander CM, Weiss TW, Gomes DR. How costeffective is the treatment of dyslipidemia in patients with diabetes but without cardivascular disease? Diabetes Care. 2001;24:45-50.